Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Report: U.S. set to buy hundreds of millions of Pfizer’s COVID-19 vaccine to share

By Sean Whooley | September 17, 2021

Pfizer-BioNTech vaccine vial

Pfizer-BioNTech COVID-19 vaccine. [Image courtesy of Wikimedia Commons]

The Biden administration reportedly plans to purchase and share with the world hundreds of millions of doses of Pfizer’s COVID-19 vaccine.

The Washington Post reported today that the U.S. has plans to make another large purchase of COVID-19 vaccines, although details of the deal have not been made clear. Neither the White House nor Pfizer have offered comment or confirmation regarding the deal, according to the report.

It seems likely that the apparent purchase comes ahead of the U.N. General Assembly next week because of an increased focus on vaccine access in lower-income countries, according to The Post. Additionally, the report noted that the White House intends to host a virtual summit on global vaccinations alongside the U.N. General Assembly next week.

The Hill said that Biden and his administration remain under pressure to do more in the effort to vaccinate the rest of the world. The U.S. has donated 140 million vaccine doses already, with an additional purchase of 500 million more doses set to be donated over 2021 and 2022 seen by advocates and experts as short of the global need.

Additionally, the FDA advisory committee is meeting today to discuss booster shots of the COVID-19 vaccine, which puts greater strain on the supply of doses as the U.S. looks to reinforce its vaccinated citizens while providing the initial vaccinations for those around the world.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Comments

  1. Ron Linden says

    September 21, 2021 at 4:44 pm

    How many doses of vaccine has Germany, England, China, Russia Saudi Arabia, etc. donated to other countries?

    Any decision on if certain segments of the US population should get a booster dose should be based on science, not on politics as to “make more vaccine avialable”
    for the rest of the world.

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE